| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | Feb 01, 2024 | Sale | $3.84 | 11,819 | 45,420 | 21,515 | Feb 02, 2024, 09:25 PM |
Menu
| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | Feb 01, 2024 | Sale | $3.84 | 11,819 | 45,420 | 21,515 | Feb 02, 2024, 09:25 PM |